FTY720D_GILENYA_NEUROSCIENCE
Drug
Novartis Pharma AG
Total Payments
$66,122
Transactions
30
Doctors
12
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $32,084 | 12 | 9 |
| 2019 | $34,037 | 18 | 7 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $27,386 | 7 | 41.4% |
| Consulting Fee | $24,271 | 12 | 36.7% |
| Travel and Lodging | $13,061 | 7 | 19.8% |
| Education | $1,093 | 1 | 1.7% |
| Food and Beverage | $310.56 | 3 | 0.5% |
Payments by Type
General
$38,735
23 transactions
Research
$27,386
7 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| CFTY720DS4897354 | Novartis Pharma AG | $15,748 | 3 |
| Publication support research related | Novartis Pharma AG | $10,514 | 3 |
| CFTY720D2404 | Novartis Pharma AG | $1,125 | 1 |
Top Doctors Receiving Payments for FTY720D_GILENYA_NEUROSCIENCE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Amit Bar-Or | Neurology | Philadelphia, PA | $16,039 | 7 |
| , MD | Neurology | Boston, MA | $10,672 | 2 |
| , M.D | Neurology | San Francisco, CA | $8,754 | 2 |
| , MD | Neurology | Cleveland, OH | $5,249 | 1 |
| , MD | Gynecology | Washington, DC | $3,968 | 4 |
| , MD | Neurology with Special Qualifications in Child Neurology | Philadelphia, PA | $3,814 | 5 |
| , M.D | Neurology | New York, NY | $3,728 | 2 |
| , MD | Neurology | Burr Ridge, IL | $3,505 | 1 |
| , MD | Neurology | Cleveland, OH | $3,505 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | Charlottesville, VA | $3,303 | 2 |
| , MD | Neurology | Dallas, TX | $2,460 | 2 |
| , MD | Pediatrics | Gainesville, FL | $1,125 | 1 |
Ad
Manufacturing Companies
- Novartis Pharma AG $66,122
Product Information
- Type Drug
- Total Payments $66,122
- Total Doctors 12
- Transactions 30
About FTY720D_GILENYA_NEUROSCIENCE
FTY720D_GILENYA_NEUROSCIENCE is a drug associated with $66,122 in payments to 12 healthcare providers, recorded across 30 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.
Payment data is available from 2019 to 2020. In 2020, $32,084 was paid across 12 transactions to 9 doctors.
The most common payment nature for FTY720D_GILENYA_NEUROSCIENCE is "Unspecified" ($27,386, 41.4% of total).
FTY720D_GILENYA_NEUROSCIENCE is associated with 3 research studies, including "CFTY720DS4897354" ($15,748).